scholarly article | Q13442814 |
P356 | DOI | 10.1126/SCIENCE.1148530 |
P698 | PubMed publication ID | 17761871 |
P50 | author | Sébastien S. Hébert | Q42384154 |
P2093 | author name string | Bart De Strooper | |
P433 | issue | 5842 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | molecular biology | Q7202 |
neurodegeneration | Q1755122 | ||
P1104 | number of pages | 2 | |
P304 | page(s) | 1179-1180 | |
P577 | publication date | 2007-08-01 | |
P1433 | published in | Science | Q192864 |
P1476 | title | Molecular biology. miRNAs in neurodegeneration | |
P478 | volume | 317 |
Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
Q35070572 | A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity |
Q39687917 | A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease. |
Q37122270 | A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. |
Q36429533 | Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing |
Q37352375 | Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus |
Q58790362 | Crosstalk between MicroRNAs and Autophagy in Adult Neurogenesis: Implications for Neurodegenerative Disorders |
Q98778829 | Effect of Moxibustion on Behavioral Changes and Expression of APP and BACE1 in Hippocampus of SAMP8 Mice |
Q24657549 | Epigenetic principles and mechanisms underlying nervous system functions in health and disease |
Q36211443 | Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction. |
Q21129257 | Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? |
Q38212483 | Expression and function of growth hormone in the nervous system: a brief review. |
Q38340344 | Fabrication of a Structure‐Specific RNA Binder for Array Detection of Label‐Free MicroRNA |
Q40209615 | Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease |
Q64240282 | Genetics and epigenetics of autism spectrum disorder-current evidence in the field |
Q27320372 | Genome-wide analysis of miRNA signature in the APPswe/PS1ΔE9 mouse model of alzheimer's disease |
Q33604717 | Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity |
Q48040725 | Identification of regulatory relationships in Parkinson's disease |
Q35208140 | In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain |
Q55346192 | Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson's disease. |
Q47959536 | Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo |
Q36609033 | Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression |
Q38009700 | Mechanism(s) of alteration of micro RNA expressions in Huntington's disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease |
Q47214829 | MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls. |
Q37617954 | MicroRNA implications across neurodevelopment and neuropathology |
Q36254253 | MicroRNA-146a rs2910164 is associated with severe preeclampsia in Black South African women on HAART. |
Q37251978 | MicroRNA-431 regulates axon regeneration in mature sensory neurons by targeting the Wnt antagonist Kremen1. |
Q38202497 | MicroRNAs and Molecular Mechanisms of Neurodegeneration. |
Q37728116 | MicroRNAs and deregulated gene expression networks in neurodegeneration |
Q41547602 | MicroRNAs as newer therapeutic targets: A big hope from a tiny player |
Q38843644 | MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments? |
Q38073708 | MicroRNAs in the brain: it's regulatory role in neuroinflammation |
Q38325601 | Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression |
Q38095915 | Molecular mechanisms of peripheral nerve regeneration: emerging roles of microRNAs |
Q34363395 | Multiplexed detection and label-free quantitation of microRNAs using arrays of silicon photonic microring resonators |
Q45338683 | Mutational screening of PARKIN identified a 3' UTR variant (rs62637702) associated with Parkinson's disease. |
Q24650444 | Nanotechnology, nanotoxicology, and neuroscience |
Q44926381 | Non-coding RNA as a trigger of neuropathologic disorder phenotypes in transgenic Drosophila |
Q92333102 | Nrf2-regulated miR-380-3p blocks the translation of Sp3 protein and its mediation of paraquat-induced toxicity in mouse neuroblastoma N2a cells |
Q33966769 | RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries |
Q37134134 | Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics |
Q31104534 | Significance of miR-196b in tumor-related epilepsy of patients with gliomas |
Q36796402 | Specification of neural cell fate and regulation of neural stem cell proliferation by microRNAs |
Q33722837 | The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. |
Q26858788 | The involvement of microRNAs in neurodegenerative diseases |
Q24608620 | The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases |
Q38070334 | The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis |
Q37369258 | Translational control of long-lasting synaptic plasticity and memory |
Q35031990 | Tumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in vitro |
Q36551516 | Unwrapping myelination by microRNAs |
Q36251998 | miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. |
Q30495998 | miRNA malfunction causes spinal motor neuron disease |
Q37535111 | miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy |
Search more.